Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial
Authors
Keywords
-
Journal
LANCET
Volume 397, Issue 10280, Pages 1195-1203
Publisher
Elsevier BV
Online
2021-03-26
DOI
10.1016/s0140-6736(21)00313-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Excess Antibiotic Treatment Duration and Adverse Events in Patients Hospitalized With Pneumonia
- (2019) Valerie M. Vaughn et al. ANNALS OF INTERNAL MEDICINE
- Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
- (2019) Joshua P. Metlay et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2018) Christopher Troeger et al. LANCET INFECTIOUS DISEASES
- Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015
- (2017) Christopher Troeger et al. LANCET INFECTIOUS DISEASES
- The New Antibiotic Mantra—“Shorter Is Better”
- (2016) Brad Spellberg JAMA Internal Medicine
- Duration of Antibiotic Treatment in Community-Acquired Pneumonia
- (2016) Ane Uranga et al. JAMA Internal Medicine
- Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
- (2015) Seema Jain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence of Antimicrobial Use in US Acute Care Hospitals, May-September 2011
- (2014) Shelley S. Magill et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Community-Acquired Pneumonia
- (2014) Daniel M. Musher et al. NEW ENGLAND JOURNAL OF MEDICINE
- A new and improved confidence interval for the Mantel-Haenszel risk difference
- (2014) Bernhard Klingenberg STATISTICS IN MEDICINE
- β-Lactam Monotherapy vs β-Lactam–Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia
- (2014) Nicolas Garin et al. JAMA Internal Medicine
- Determining the Duration of Therapy for Patients with Community-Acquired Pneumonia
- (2013) Nikole M. Scalera et al. Current Infectious Disease Reports
- Guidelines for the management of adult lower respiratory tract infections - Summary
- (2011) M. Woodhead et al. CLINICAL MICROBIOLOGY AND INFECTION
- Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia
- (2009) S. Aliberti et al. EUROPEAN RESPIRATORY JOURNAL
- The Maxwell Finland Lecture: For the Duration-- Rational Antibiotic Administration in an Era of Antimicrobial Resistance and Clostridium difficile
- (2008) L. B. Rice CLINICAL INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now